Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord mesenchymal stem cell transplantation for type 2 diabetes
ChiCTR-ONC-10000985Phase 4Completed
- Sponsor
- Armed Police General Hospital
- Start
- May 2010
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus (T2DM), sponsored by Armed Police General Hospital. Primary endpoints: Blood sugar, Glycated hemoglobin and 2 more. Started May 2010; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-ONC-10000985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-10000985.